Company data sheet · Molecular Data
Molecular Data: four lost years, and the economy wasn't the reason.
- Industry
- Business Services
- Headquarters
- China
- Sources
- SEC filings (2019–2025), Stratrix's verified Decision Cases, market data and official economic statistics for China
- Data as of
- October 18, 2026
- From profit to four straight losses. Molecular Data lost money every year from 2017 to 2020: CN¥0.9 billion in all.
- It wasn't the cycle. The losses began in 2017, a year China economy grew 6.9%. When a company falls while its economy grows, look inside the company first.
- Still smaller than it was. Revenue reached CN¥7.6 billion in 2020, 42% below its 2019 peak of CN¥13.2 billion.
Financial results
| Fiscal year | Revenue | Net income | |
|---|---|---|---|
| 2017 | CN¥4.2 billion | −CN¥0.1 billion | |
| 2018 | CN¥9.1 billion | −CN¥0.3 billion | |
| 2019 | CN¥13.2 billion | −CN¥0.2 billion | |
| 2020 | CN¥7.6 billion | −CN¥0.3 billion |
As reported in its annual filings, in CNY. Losses in red.
The full data sheet · Data Plan
Everything behind these findings, ready for your board deck.
- Economic context: 3 measures for China, every year since 2016, from the official sources.
- Peer comparison: against 528 companies of its size in its sector.
- Financial results: ten years of revenue, operating and net income, and every annual report, linked.
- Methods and sources, so each number can be checked and cited.
The full data sheet downloads with the Data Plan. To see exactly what you get first, open the Boeing sample PDF or Excel.